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Abstract Periodontitis is a common chronic inflammatory
disease characterised by destruction of the supporting struc-
tures oftheteeth(theperiodontal ligamentandalveolarbone).
It is highly prevalent (severe periodontitis affects 10–15% of
adults) and has multiple negative impacts on quality of life.
Epidemiological data confirm that diabetes is a major risk
factor for periodontitis; susceptibility to periodontitis is
increased by approximately threefold in people with diabetes.
There is a clear relationship between degree of hyper-
glycaemia and severity of periodontitis. The mechanisms that
underpin the links between these two conditions are not
completely understood, but involve aspects of immune
functioning, neutrophil activity, and cytokine biology. There
is emerging evidence to support the existence of a two-way
relationship between diabetes and periodontitis, with diabetes
increasing the risk for periodontitis, and periodontal inflam-
mation negatively affecting glycaemic control. Incidences of
macroalbuminuria and end-stage renal disease are increased
twofold and threefold, respectively, in diabetic individuals
who also have severe periodontitis compared to diabetic
individuals without severe periodontitis. Furthermore, the risk
of cardiorenal mortality (ischaemic heart disease and diabetic
nephropathy combined) is three times higher in diabetic
people with severe periodontitis than in diabetic people
without severe periodontitis. Treatment of periodontitis is
associated with HbA1c reductions of approximately 0.4%.
Oral and periodontal health should be promoted as
integral components of diabetes management.
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The two-way relationship between diabetes
and periodontitis
What is periodontitis?
Periodontal diseases are collectively the most common
diseases known to mankind. Their classification is complex
and takes into account the clinical presentation, age at
diagnosis, rate of disease progression, and systemic and
local factors that may increase risk. Periodontal diseases
include gingivitis (in which the inflammation is confined to
the gingiva, and is reversible with good oral hygiene) and
periodontitis (in which the inflammation extends and results
in tissue destruction and alveolar bone resorption). Tissue
destruction in periodontitis results in breakdown of the
collagen fibres of the periodontal ligament, resulting in the
formation of a periodontal pocket between the gingiva and
the tooth. ‘Pocketing’ is not evident on simple visual
inspection, and assessment using a periodontal probe is
essential. Periodontitis is a slowly progressing disease but
the tissue destruction that occurs is largely irreversible. In
the early stages, the condition is typically asymptomatic; it
is not usually painful, and many patients are unaware until
the condition has progressed enough to result in tooth
mobility. The pockets deepen as a result of the further
destruction of fibres of the periodontal ligament (referred to
as attachment loss; Fig. 1) and the resorption of the alveolar
bone that occurs in parallel with the progressing attachment
loss. Advanced periodontitis is characterised by gingival
erythema and oedema, gingival bleeding, gingival recession,
tooth mobility, drifting of teeth, suppuration from periodontal
pockets, and tooth loss.
The condition is very common, with severe periodontitis
that threatens tooth retention affecting 10–15% of adults in
most populations studied [1–3]. Moderate periodontitis is
even more common, affecting 40–60% of adults. Perio-
dontitis is therefore a highly prevalent, but largely hidden,
chronic inflammatory disease. Furthermore, it has negative
and profound impacts on many aspects of daily living and
quality of life, affecting confidence, social interactions and
food choices [4]. Smoking is a major risk factor; it
significantly increases risk for periodontitis and severity
of the condition [5, 6]. Other risk factors for periodontal
diseases include diabetes, conditions associated with
compromised immune responses (e.g. HIV), nutritional
defects, osteoporosis, medications that cause drug
induced gingival overgrowth (e.g. some calcium channel
blockers, phenytoin, ciclosporin), genetic factors (as yet
poorly defined), and local factors (e.g. anatomical
deficiencies in the alveolar bone) [5].
Associations between diabetes and periodontitis
Diabetes has been unequivocally confirmed as a major risk
factor for periodontitis [7–9]. The risk of periodontitis is
increased by approximately threefold in diabetic individuals
compared with non-diabetic individuals [10]. The level of
glycaemic control is of key importance in determining
increased risk. For example, in the US National Health and
Nutrition Examination Survey (NHANES) III, adults with
an HbA1c level of >9% had a significantly higher
prevalence of severe periodontitis than those without
diabetes (OR 2.90; 95% CI 1.40, 6.03) after controlling
for age, ethnicity, education, sex and smoking [11]. The
importance of diabetes as a major risk factor for
periodontitis became apparent in the 1990s in a number
of cross-sectional and longitudinal studies investigating
the Pima Indian population. The prevalence and inci-
dence of periodontitis were greater in Pima Indians who
Pocket depth
Attachment
loss 
Base of pocket
CEJ
R
o
o
t
 
s
u
r
f
a
c
e
Enamel
Gingiva
Pocket
Top of pocket
Insertion of periodontal probe
Fig. 1 Diagram of periodontal pocket in a patient with periodontitis.
The pocket is the space between the root surface and the gingiva. In
healthy gums, the base of the pocket is coincident with the cemento-
enamel junction (CEJ, the boundary between the enamel crown and
the root) and there is no attachment loss. In periodontitis, the base of
the pocket migrates apically (i.e. away from the enamel crown towards
the root tip), thereby creating a pocket. The base of the pocket is
therefore apical to the CEJ, and attachment loss can be measured (in
mm, using a periodontal probe) from the CEJ to the base of the
pocket. Pocket depth (also called probing depth) is measured in mm
from the top of the pocket (i.e. from the gingival margin) to the base
of the pocket. In this example, the pocket depth might be 6 mm, with
4 mm loss of attachment (as indicated in this example, pocket depth is
usually greater than attachment loss due to the inflammation-induced
swelling of the gingiva). The direction of insertion of a periodontal
probe is indicated
22 Diabetologia (2012) 55:21–31had type 2 diabetes mellitus compared with those who
did not [12, 13], with an approximately threefold
increased risk for periodontitis [14]. The majority of
research has focused on type 2 diabetes mellitus as a risk
factor for periodontitis, probably because both diseases
have historically tended to develop in patients in their 40s
and 50s. However, type 1 diabetes mellitus also increases
the risk of periodontitis, and all patients with diabetes
(including children and young adults) should be considered to
beatincreased riskofperiodontitis.Oneearly study identified
that around 10% of children (<18 years) with type 1 diabetes
mellitus had increased attachment loss and bone loss
compared with controls, despite comparable plaque scores
[15]. More recently, in a study of 350 diabetic children (6–
18 years old) vs 350 non-diabetic controls, the proportion of
periodontal sites with evidence of periodontitis was greater
in the children with diabetes (>20% vs 8% of sites,
respectively) [16].
Dentists have long been aware of the importance of a
diagnosis of diabetes in their patients, and various oral
conditions are associated with diabetes, including xerosto-
mia and candidal infections as well as periodontitis. In the
early 1990s periodontitis was sometimes referred to as the
‘sixth complication of diabetes’ [17], and in 2003 the ADA
acknowledged that periodontal disease is often found in
people with diabetes [18]. The clinical and radiographic
appearance of periodontitis is shown in Figs 2 and 3.
Associations between obesity and periodontitis
Other lifestyle factors such as obesity, physical activity and
diet are also likely to affect the risk of periodontitis. One of
the first studies to show an effect of obesity on periodontitis
identified that obese rats with periodontitis had more
alveolar bone loss compared with non-obese rats [19].
Adiposity can be regarded as a systemic disease that
predisposes individuals to a variety of comorbidities and
complications, and a number of studies have reported
associations between obesity and periodontitis [20].
Analysis of NHANES III data identified that individuals
with a BMI of ≥30 kg/m
2 had a significantly increased risk
of periodontitis compared with individuals with a BMI of
18.5–24.9 kg/m
2 [21]. This relationship was potentially
mediated by insulin resistance since, among those with a
BMI of ≥27 kg/m
2, those who were in the highest quartile
for insulin resistance had a significantly increased risk of
severe periodontitis compared with those in the lowest
quartile [22]. A recent meta-analysis revealed a significant
association between periodontitis and obesity (OR 1.35;
95% CI 1.23, 1.47), and concluded that a higher
prevalence of periodontitis should be expected among
obese adults [23].
These findings raise the question of whether increased
physical activity can reduce periodontitis risk. In the US
Health Professionals Follow-up Study of 39,467 health
professionals, an inverse linear relationship was identified
between sustained physical activity and periodontitis,
Fig. 2 Periodontitis (clinical appearance) in a 22-year-old man with
poorly controlled type 1 diabetes and severe periodontitis. Note the
generalised inflammation, abnormal gingival anatomy owing to tissue
destruction, gingival recession, swelling and inflammation, spontane-
ous bleeding and abundant plaque deposits. The periodontal tissues
around the lower incisors are particularly severely affected
Fig. 3 Periodontitis (radiographic appearance). a A 42-year-old man
with type 2 diabetes and generalised severe periodontitis. There is
extensive alveolar bone loss (generally 50–75% of the root length)
affecting the entire dentition, with an irregular (uneven) pattern of
bone loss. Some of the teeth have lost nearly all their supporting
alveolar bone as a result of periodontitis progression, e.g. the upper
molars (both right and left), and the four lower incisors, all of which
are grossly mobile and which are retained in the oral cavity only by
the soft tissue attachment (having lost 100% of their bone support). b
A 21-year-old man with no periodontitis. Alveolar bone levels are
normal, with the crest of the alveolar bone being in close proximity to
the cemento-enamel junction (the boundary between the enamel
crown and the root). Contrast with appearance in Fig. 3a
Diabetologia (2012) 55:21–31 23independent of known risk factors [24]. Another analysis of
NHANES III data revealed that adults with higher levels of
physical activity had significantly lower risk of periodonti-
tis, with associations being strongest in non-smokers (but
no association in smokers, suggesting that the harmful
effects of smoking outweighed any benefit of physical
activity) [25]. These various studies, while interesting, are
limited in that they are generally cross-sectional/observation-
al, and the temporal sequence of events is not clear (i.e.
whether obesity precedes periodontitis). Prospective cohort
studies are required to evaluate this area further.
Impact of periodontitis on diabetes
There has recently been much emphasis on the ‘two-way’
relationship between diabetes and periodontitis [26]. That
is, not only is diabetes a risk factor for periodontitis, but
periodontitis could have a negative effect on glycaemic
control. The first clear evidence to support this hypothesis
came from investigations of individuals in the Gila River
Indian community. Severe periodontitis at baseline was
associated with an increased risk of poor glycaemic control
(HbA1c>9.0%) at follow-up (minimum 2 years), suggesting
that severe periodontitis was a risk factor for compromised
diabetes management [27]. In addition, various studies have
reported that the prevalence and severity of non-oral
diabetes-related complications, including retinopathy,
diabetic neuropathy, proteinuria and cardiovascular complica-
tions, are correlated with the severity of periodontitis [28–31].
Further studies of the Gila River Indian Community
investigated the effect of periodontitis on the development of
overt nephropathy, defined as macroalbuminuria and end-
stage renal disease (ESRD), in type 2 diabetes mellitus [32].
Periodontal status was assessed in 529 individuals aged
≥25 years old who had type 2 diabetes mellitus, a glomerular
filtration rate of ≥60 ml min
−1 1.73 m
−2, and no macro-
albuminuria (urinary albumin:creatinine ratio ≥300 mg/g). A
total of 193 individuals developed macroalbuminuria (over a
median follow-up of 9.4 years) and 68 developed ESRD
(over a median follow-up of 14.9 years). After adjusting for
age, sex, diabetes duration, BMI and smoking, the incidences
of macroalbuminuria were 2.0, 2.1 and 2.6 times as high in
those with moderate periodontitis, severe periodontitis, or
who were edentulous, respectively, compared with those
with no/mild periodontitis (p<0.05). The incidences of
ESRD were 2.3, 3.5 and 4.9 times as high for those with
moderate or severe periodontitis or who were edentulous,
respectively (p<0.05). Thus, moderate and severe perio-
dontitis and edentulousness predicted the development of
overt nephropathy and ESRD in a ‘dose-dependent’
manner in individuals with type 2 diabetes mellitus and
little or no pre-existing kidney disease [32].
The same researchers also investigated the effect of
periodontitis on deaths from cardiovascular disease and
diabetic nephropathy. In a prospective longitudinal study of
628PimaIndiansaged≥35yearswithtype2diabetesmellitus
(median follow-up 11 years, during which 204 participants
died), age- and sex-adjusted death rates (deaths per 1,000
person-years) were 3.7 for those with noor mildperiodontitis,
19.6 for moderate periodontitis and 28.4 for severe perio-
dontitis. Periodontitis was a predictor of deaths from
ischaemic heart disease (p=0.04) and diabetic nephropathy
(p<0.01). After adjusting for age, sex, diabetes duration,
HbA1c, macroalbuminuria, BMI, cholesterol, hypertension,
electrocardiogram abnormalities and smoking, diabetic indi-
viduals with severe periodontitis had 3.2 times the risk (95%
CI 1.1, 9.3) of cardiorenal mortality (ischaemic heart disease
and diabetic nephropathy combined) compared with the
reference group (no/mild periodontitis and moderate perio-
dontitis combined) [33].
Acknowledging that the above studies were conducted in
a specific, defined population, more recent research has
investigated the impact of oral disease on subsequent
cardiovascular disease in a general population of people
with type 2 diabetes mellitus [34]. A total of 10,958
participants responded to two questions about the presence
of oral disease (the number of natural teeth in their mouth,
and the approximate number of days their gums had bled in
the previous year) [35]; a lower number of remaining
natural teeth and higher number of bleeding days were
taken as indicators of poorer oral health. Despite the
relatively crude oral health measures that were ascertained,
age-, sex- and treatment allocation-adjusted analyses
revealed that the group with no teeth were at almost twice
the risk of death from all causes relative to those with ≥22
teeth; people with 1–21 teeth had an intermediate risk. The
authors of the paper postulated that inflammation resulting
from poor oral health may have been implicated in the
development of cardiovascular disease.
An intriguing area of recent investigation has focused on
whether periodontitis plays a role in the incidence of
diabetes. In a 7 year prospective study of 5,848 non-
diabetic individuals aged 30–59 years, the effect of
periodontitis on diabetes incidence (defined as fasting
plasma glucose >6.9 mmol/l, equivalent to >125 mg/dl)
was assessed [36]. In unadjusted analyses, moderate
(pockets 3.5–5.5 mm) and severe (pockets >5.5 mm) perio-
dontitis were significantly associated with an increased risk of
diabetesincidence,butsignificancewaslostafteradjustingfor
sex, smoking, BMI, triacylglycerol, hypertension, HDL-
cholesterol, and g-glutamyl transpeptidase.
The impact of periodontitis on changes in HbA1c was
assessed in a prospective 5 year study of 2,973 non-diabetic
individuals [37]. Those participants with the most advanced
24 Diabetologia (2012) 55:21–31periodontitis at baseline demonstrated an approximately
fivefold greater absolute increase in HbA1c over the 5 years
of the study compared with those with no periodontitis at
baseline (change in HbA1c 0.106±0.03% vs 0.023±0.02%).
This was the first study to report that periodontitis predicts
the progression of HbA1c among diabetes-free individuals
and it is continuing to identify whether these subclinical
changes in HbA1c may translate into an increased risk of
incident diabetes at 10 years.
What are the pathogenic mechanisms linking diabetes
and periodontitis?
Periodontitis is a complex chronic inflammatory disease in
which inflammation in the periodontal tissues is stimulated
by the long-term presence of the subgingival biofilm
(dental plaque). The inflammatory response is characterised
by dysregulated secretion of host-derived mediators of
inflammation and tissue breakdown. The most extensively
studied include IL-1β, IL-6, prostaglandin E2 (PGE2),
TNF-α, receptor activator of nuclear factor κB ligand
(RANKL), and the matrix metalloproteinases (MMPs;
particularly MMP-8, MMP-9 and MMP-13), as well as T
cell regulatory cytokines (e.g. IL-12, IL-18) and the
chemokines [38]. The complexity of cytokine networks in
periodontal pathogenesis is becoming increasingly appar-
ent, and it is clear that there is considerable heterogeneity in
thenatureoftheinflammatoryresponsebetween individuals.
This heterogeneity exists not only between individuals, but
also within individuals over time, and is influenced by
genetic, epigenetic and environmental factors. The sum
total of the inflammatory response in the periodontal
tissues determines the pattern and rate of disease
progression [39].
Inflammation is a central feature of the pathogenesis
of diabetes and periodontitis
Both type 1 and type 2 diabetes mellitus are associated with
elevated levels of systemic markers of inflammation [40]. The
elevated inflammatory state in diabetes contributes to both
microvascular and macrovascular complications, and it is
clear that hyperglycaemia can result in the activation of
pathways that increase inflammation, oxidative stress and
apoptosis [41]. Elevated serum levels of IL-6 and TNF-α
have been demonstrated in diabetes and obesity [40], and
serum levels of IL-6 and C-reactive protein (CRP) have been
shown to predict future occurrence of type 2 diabetes mellitus
[42]. Elevated levels of CRP are also associated with insulin
resistance, type 2 diabetes mellitus and cardiovascular disease
[43]. TNF-α and IL-6 are the main inducers of acute-phase
proteins, including CRP, and both have been shown to impair
intracellular insulin signalling, potentially contributing to
insulin resistance [44, 45]. Serum levels of IL-6 and CRP
are also raised in patients with periodontitis, with IL-6 levels
correlating with the extent of disease [46, 47]. The systemic
inflammation that is associated with periodontal disease may
therefore enhance the diabetic state. Adipokines may also
contribute to susceptibility to both periodontitis and diabetes,
and the proinflammatory properties of leptin may be
particularly important in upregulating periodontal inflamma-
tion in people who are obese and/or have type 2 diabetes
mellitus [48].
Diabetes increases inflammation in the periodontal
tissues. For example, gingival crevicular fluid (GCF; a
fluid exudate that flows from the gingival margins)
levels of PGE2 and IL-1β are higher in type 1 diabetic
patients with either gingivitis or periodontitis compared
with those in non-diabetic individuals with the same level
of periodontal disease [49]. In a study of type 2 diabetic
patients, those with HbA1c >8% had a significantly higher
GCF IL-1β level compared with patients with HbA1c <8%,
and both HbA1c and random glucose were independent
predictors of an elevated GCF IL-1β level [50].
Whenchallengedwithlipopolysaccharide,monocytes from
type 1 diabetic patients produce significantly greater concen-
trations of TNF-α,I L - 1 β and PGE2 than monocytes from
non-diabetic individuals [49, 51]. Furthermore, studies have
consistently demonstrated defects in polymorphonuclear
leucocyte (PMN) activity in patients with diabetes, including
impaired chemotaxis, phagocytosis and microbicidal func-
tions [52]. PMNs require energy to function and these defects
may be related to the metabolic changes that occur in diabetes
[53]. Diabetic patients with severe periodontitis have been
shown to have depressed PMN chemotaxis compared with
diabetic individuals with mild periodontitis [54], as well as
defective PMN apoptosis [55], which may lead to increased
retention of PMNs in the periodontal tissue, leading to more
tissue destruction by continued release of MMPs and reactive
oxygen species (ROS). Diabetes prolongs the inflammatory
response to Porphyromonas gingivalis (a periodontal patho-
gen commonly found in the biofilm of patients with advanced
periodontitis), with increased production of TNF-α [56].
Periodontal treatment has been shown to reduce serum levels
Studies show that the incidences of macroalbuminuria
and end-stage renal disease are  increased twofold and
threefold, respectively, in diabetic individuals who also
have  severe  periodontitis.  Furthermore,  people  with 
diabetes  and  severe  periodontitis  have  a  three  times
higher risk of cardiorenal mortality compared with those
without severe periodontitis.  
Diabetologia (2012) 55:21–31 25of inflammatory mediators, including IL-6, TNF-α, CRP and
MMPs, in patients with and without diabetes [47, 57–60]
Accumulation of AGEs in the periodontal tissues is also
likelytoplayaroleinupregulatingperiodontalinflammationin
individuals with diabetes. Binding of AGE to its receptor
(RAGE) results in the upregulated production of inflammatory
mediators such as IL-1β, TNF-α and IL-6 [61]. AGE
formation results in the production of ROS and enhances
oxidant stress, and the subsequent endothelial cell changes
that occur contribute to the vascular injury implicated in many
diabetes complications [62]. AGEs also enhance the respira-
tory burst in PMNs [63], which has the potential to
significantly increase local tissue damage in periodontitis.
Furthermore, AGEs have detrimental effects on bone
metabolism, leading to impaired repair and bone formation
[64] and decreased extracellular matrix production [65].
Apoptosis may also play a role in the increased suscep-
tibility to periodontitis associated with diabetes, and
apoptosis of matrix-producing cells may limit the oppor-
tunities for repair in inflamed tissues. Induction of tissue
injury by inoculation with P. gingivalis resulted in signifi-
cantly higher fibroblast apoptosis in diabetic mice compared
with non-diabetic mice [66], indicating another mechanism
by which diabetes can interfere with the capacity for repair in
inflamed periodontal tissues. The various inflammatory
pathways postulated to link diabetes and periodontitis are
illustrated in Fig. 4.
Is there a relationship between the oral microbiota
and diabetes?
Compared with the large number of studies that have
investigated the role of inflammatory mechanisms in the link
between periodontitis and diabetes, relatively few have
investigated relationships between the oral microbiota and
diabetes. In one study, recovery of several periodontal
pathogens, including Aggregatibacter actinomycetemcomi-
tans, Campylobacter rectus, Capnocytophaga spp, Eikenella
corrodens, Fusobacterium nucleatum and Prevotella inter-
media, was similar in both diabetic and non-diabetic
participants, but significantly more individuals with diabetes
harboured P. gingivalis [67]. Similarly, in a study of young
Japanese individuals with type 1 diabetes mellitus, a greater
proportion of participants with periodontitis harboured P.
gingivalis and P. intermedia than those who were periodon-
tally healthy [68]. These studies indicate that there are
probably subtle differences in the microbial composition of
the subgingival biofilm between individuals with diabetes and
those without, but the clinical relevance of this is not clear.
Such differences may arise from the effect of diabetes in
altering the local environment within the periodontal pocket
such that the growth of certain bacterial species is favoured.
The contribution of oral bacteria to adiposity has also
been assessed. In a study of 313 women with BMI of 27–
32 kg/m
2 (compared with 232 healthy individuals), 98.4%
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Fig. 4 Schematic representation of the proposed two-way relationship
between diabetes and periodontitis. Exacerbated and dysregulated
inflammatory responses are at the heart of the proposed two-way
interaction between diabetes and periodontitis (purple box), and the
hyperglycaemic state results in various proinflammatory effects that
impact on multiple body systems, including the periodontal tissues.
Adipokines produced by adipose tissue include proinflammatory
mediators such as TNF-α, IL-6 and leptin. The hyperglycaemic state
results in deposition of AGEs in the periodontal tissues (as well as
elsewhere in the body), and binding of the receptor for AGE (RAGE)
results in local cytokine release and altered inflammatory responses.
Neutrophil function is also altered in the diabetic state, resulting in
enhancement of the respiratory burst and delayed apoptosis (leading to
increased periodontal tissue destruction). Local production of cyto-
kines in the periodontal tissues may, in turn, affect glycaemic control
through systemic exposure and an impact on insulin signalling (dotted
arrow). All of these factors combine to contribute to dysregulated
inflammatory responses that develop in the periodontal tissues in
response to the chronic challenge by bacteria in the subgingival
biofilm, and which are further exacerbated by smoking
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presence of the periodontal pathogen Selenomonas noxia
at levels >1.05% of the total bacterial population [69]. S.
noxia >1.05% had a sensitivity of 98% and specificity of
80% of predicting obesity, leading to the interesting
question of whether oral bacteria are involved in the
pathology that leads to obesity. The tenets of ‘infectobesity’
suggest that the gut microbiota of obese individuals may be
more efficient at extracting energy from a given diet than
that of lean individuals [70, 71], and gut microorganisms
can affect host metabolism, influencing inflammation and
insulin resistance [72]. The role of swallowed periodontal
bacteria in contributing to these effects has yet to be
established, but it is clear from animal studies that
influencing the intestinal microbiota (for example, through
the use of prebiotics, specific nutrients, or natural anti-
biotics) could potentially change satiety and insulin
resistance and be of benefit in the management of diabetes
[73, 74].
Periodontal treatment is associated with improved
glycaemic control
Several meta-analyses have confirmed that effective peri-
odontal therapy can result in reduced HbA1c. The first
reported on ten interventional studies with a combined
population of 456 patients; the authors identified a
weighted mean reduction in HbA1c of 0.66% as a result
of periodontal therapy (though this failed to achieve
statistical significance) [75]. In 2008, a meta-analysis of
nine studies involving 485 patients reported a significant
reduction of HbA1c of 0.46% following periodontal
treatment [76]. In 2010, a meta-analysis of five studies
involving 371 patients also reported a significant weighted
mean reduction in HbA1c of 0.40% over a follow-up period
of 3–9 months after periodontal therapy [77]. The authors
of these meta-analyses all commented on the heterogeneity
of the data, different methodologies having being used in
the different studies. Most recently, the Cochrane Collab-
oration has reported on studies that investigated the
relationship between periodontal treatment and glycaemic
control in people with diabetes [78]. Three studies were
included in this meta-analysis which reported a significant
reduction in HbA1c of 0.40% 3–4 months after convention-
al periodontal therapy (Fig. 5). The findings of these meta-
analyses are supported a recent population-based study of
over 5,000 individuals with diabetes [79] reporting that
patients who received at least one episode of periodontal
surgery (an intense form of periodontal treatment, not
routinely undertaken in all patients with periodontitis) had
HbA1c levels that were 0.25% lower than patients who did
not undergo periodontal surgery [80–82].
Taken collectively, the evidence supports the notion
that improvements in metabolic control can be antici-
pated following effective treatment of periodontitis
(although there are few studies available, and some
studies lack power). The mechanisms by which this
occurs are not yet clear, but probably relate to reduced
systemic inflammation (e.g. reduced serum levels of
mediators such as TNF-α and IL-6) following the
treatment and resolution of periodontal inflammation.
Larger randomised trials are warranted to investigate
this further. These observations are important because
reductions in HbA1c are associated with a reduced risk of
diabetes complications. For example, each 1% reduction
in HbA1c has been associated with reductions in risk of
21% for any endpoint related to diabetes, 21% for deaths
related to diabetes, 14% for myocardial infarction and
37% for microvascular complications [83].
The healthcare implications of the link between diabetes
and periodontitis
In 2000, the US Surgeon General referred to a ‘silent
epidemic’ of oral and dental diseases, and stressed the
importance of oral health as being essential for general
health and well-being [84]. In 2007, the WHO Executive
Board acknowledged the intrinsic link between oral health,
general health and quality of life [85]. A recent editorial in
The Lancet stated that ‘oral health is a neglected area of
global health’ and indicated that promoting and improving
oral health should be part of the routine business of
healthcare policymakers and clinicians [86]. Because poor
oral health primarily affects morbidity rather than mortality,
policymakers and governments have unfortunately tended
to view oral diseases as less important than more life-
threatening diseases. However, oral diseases are highly
prevalent and are associated with significant morbidity:
dental caries is one of the most prevalent diseases
worldwide, severe periodontitis typically affects up to
15% of most adult populations, oral cancer is the eighth
most common cancer worldwide, and approximately half of
people who are HIV positive have oral fungal, bacterial or
viral infections [86].
The management of diabetes is complex and the
prevention of cardiovascular and microvascular disease,
through early detection and management of complications,
are key components. Lifestyle intervention, education, self-
management and self-monitoring are particularly important,
Meta-analyses indicate that HbA1c reductions of around
0.4% can be anticipated following effective periodontal
therapy. 
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pressure and lipids [87]. Similar to diabetes, current
treatment philosophies for periodontitis strongly emphasise
self-management through patient education. A supportive
and facilitative approach by the dental team is essential, but
there must be a clear understanding that patient-performed
plaque control is the vehicle by which to control the
inflammation which drives periodontal tissue destruction.
Structured education programmes are effective in the
management of diabetes [88–90], and similar programmes
are being developed for the management of periodontitis
[91, 92]. These education programmes all emphasise the
importance of engaging with the patient and ensuring that
patients develop self-efficacy in managing their disease as
the means to effect the lifelong behavioural changes that are
required for the successful management of both conditions.
The importance of self-efficacy in the control of diabetes
and oral hygiene has been demonstrated in a population of
diabetic individuals in Finland. Those individuals with
better tooth-brushing self-efficacy had lower plaque scores
(as might be expected) and lower HbA1c levels compared
with those who had poorer self-efficacy [93]. Furthermore,
diabetic participants who managed their gingivitis success-
fully also tended to report better glycaemic control and had
lower mean HbA1c levels (8.1±1.5%) compared with
participants who did not manage their gingivitis effectively
(9.0±1.9%) [94]. These studies suggest that there are
common determinants for both dental and diabetes self-
care that could be exploited for improved management of
both conditions.
There is, therefore, a cogent argument for involving
the dental team in the management of diabetes. Indeed,
the dental team is well placed to screen patients for
diabetes by virtue of the fact that many people visit
their dentist regularly (e.g. every 6 months, often more
frequently than they visit their medical practitioner), and
the intra-oral findings may raise suspicion of undiag-
nosed diabetes. The dental team (particularly dental
hygienists) are very adept and experienced in instituting
behavioural changes in their patients, and may represent
an untapped source of support for medical colleagues in
this role.
Conclusions
Epidemiological studies confirm that diabetes is a
significant risk factor for periodontitis, and the risk of
periodontitis is greater if glycaemic control is poor;
people with poorly controlled diabetes (who are also
Experimental Control Mean difference Mean difference
Study or subgroup  Mean SD Total Mean SD  Total Weight IV, fixed, 95% Cl IV, fixed, 95% Cl
Studies without antibiotics 
Kiran et al, 2005 [81] 6.51 0.8 22 7.31 2.08 22 16.7% –0.80 (–1.73, 0.13)
Subtotal (95% CI) 22 22 16.7% –0.80 (–1.73, 0.13)
Heterogeneity: Not applicable
Test for overall effect: Z = 1.68 (p = 0.09) 
Studies with adjunctive antibiotics in test group 
Jones et al, 2007 [80] 9.22 1.56 74 9.58 1.42 80 65.1% –0.36 (–0.83, 0.11)
Subtotal (95% CI) 74 80 65.1% –0.36 (–0.83, 0.11)
Heterogeneity: Not applicable
Test for overall effect: Z = 1.49 (p = 0.14) 
Studies with antibiotics in both test and control groups 
Yun et al, 2007 [82] 7.49 1.34 23 7.64 1.73 23 18.2% –0.15 (–1.04, 0.74)
Subtotal (95% CI) 23 23 18.2% –0.15 (–1.04, 0.74]
Heterogeneity: Not applicable
Test for overall effect: Z = 0.33 (p = 0.74) 
Total (95% CI) 119 125 100.0% –0.40 (0.78, –0.01)
Heterogeneity: X   = 1.04, df = 2 (p = 0.60); I   = 0%
Test for overall effect: Z = 2.03 (p = 0.04) 
Test for subgroup differences: X   = 1.04, df = 2 (p = 0.60); I   = 0% –2 0 2
Favours experimental  Favours control
²
²
²
²
Fig. 5 Forest plot to indicate outcome of periodontitis treatment on
HbA1c levels after 3–4 months. The effect for the mean percentage
difference as a result of periodontal treatment was −0.40% (95% CI
0.78%,−0.01%),n=244, representing a statistically significant reduction
in HbA1c (p=0.04) as a result of the periodontal treatment. IV, inverse
variance (from Simpson TC, Needleman I, Wild SH, Moles DR, Mills
EJ Treatment of periodontal disease for glycaemic control in people
with diabetes. Cochrane Database Syst Rev, 2010, Issue 5. Copyright
Cochrane Collaboration, reproduced with permission)
The parallels between patient responsibilities in managing
their   diabetes  or  periodontitis   are  striking.  Successful
treatment   of   periodontitis   involves  structured   patient 
education and empowerment, establishing treatment needs
and  setting  goals,  personalised  biofeedback  (e.g. 
reductions  in  gingival  bleeding  and  probing  depths),
frequent  recall, and  the involvement of various members 
of  the  dental  team,  particularly  dental  hygienists.  
28 Diabetologia (2012) 55:21–31most at risk for the other macrovascular and microvascular
complications) are at an increased risk of periodontitis
and alveolar bone loss [5, 95]. Given the predicted
increases in the prevalence of diabetes over the next few
decades, we will probably see a reversal of the hitherto
experienced reductions in the prevalence of periodontitis
(associated with less smoking and better oral healthcare
behaviours over recent years) as a result of large increases
in the number of people with diabetes [96]. Controlling
diabetes (i.e. improving glycaemic control) is likely to
reduce the risk and severity of periodontitis. Furthermore,
evidence suggests that resolution of periodontal inflam-
mation can improve metabolic control (with reported
HbA1c reductions of approximately 0.4%), though large,
multi-centre, randomised controlled trials are needed to
further validate these findings.
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